Publications
Journals
- Ali OF; Growcott EJ; Butrous GS; Wharton J. (2011). Pleiotropic effects of statins in distal human pulmonary artery smooth muscle cells. Respir Res. 12:137. DOI.
- Rhodes CJ; Howard LS; Busbridge M; Ashby D; Kondili E; Gibbs JS; Wharton J; Wilkins MR. (12 Jul 2011). Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights. J Am Coll Cardiol. 58:300-309. DOI.
- Rhodes CJ; Wharton J; Howard LS; Gibbs JS; Wilkins MR. (Jul 2011). Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart. 97:1054-1060. DOI.
- Rhodes CJ; Wharton J; Howard L; Gibbs JS; Vonk-Noordegraaf A; Wilkins MR. (Dec 2011). Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target. Eur Respir J. 38:1453-1460. DOI.
- Abdul-Salam VB; Wharton J; Cupitt J; Berryman M; Edwards RJ; Wilkins MR. (16 Nov 2010). Proteomic analysis of lung tissues from patients with pulmonary arterial hypertension. Circulation. 122:2058-2067. DOI.
- Diller G-P; Thum T; Wilkins MR; Wharton J. (1 Jan 2010). Endothelial Progenitor Cells in Pulmonary Arterial Hypertension. TRENDS IN CARDIOVASCULAR MEDICINE. 20:22-29.
- Wilkins MR; Ali O; Bradlow W; Wharton J; Taegtmeyer A; Rhodes CJ; Ghofrani HA; Howard L; et alNihoyannopoulos P; Mohiaddin RH; Gibbs JS; Simvastatin Pulmonary Hypertension Trial (SiPHT) Study Group. (15 May 2010). Simvastatin as a treatment for pulmonary hypertension trial. Am J Respir Crit Care Med. 181:1106-1113. DOI.
- Zhao L; Sebkhi A; Ali O; Wojciak-Stothard B; Mamanova L; Yang Q; Wharton J; Wilkins MR. (1 Oct 2009). Simvastatin and sildenafil combine to attenuate pulmonary hypertension. EUROPEAN RESPIRATORY JOURNAL. 34:948-957. Author weblink DOI.
- Zhao Y-Y; Zhao YD; Mirza MK; Huang JH; Potula H-HSK; Vogel SM; Brovkovych V; Yuan JX-J; et alWharton J; Malik AB. (1 Jul 2009). Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. JOURNAL OF CLINICAL INVESTIGATION. 119:2009-2018. Author weblink DOI.
- Diller G-P; Bedard E; Wort SJ; Gatzoulis MA; van Eijl S; Ali O; Wilkins MR; Wharton J; et alOkonko DO; Howard LS; Thum T; Bauersachs J; Gibbs JSR; Hobbs AJ. (10 Mar 2009). Response to Letter Regarding Article, "Circulating Endothelial Progenitor Cells in Patients With Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension". CIRCULATION. 119:E231-E231. Author weblink DOI.
- Rhodes CJ; Davidson A; Gibbs JS; Wharton J; Wilkins MR. (Jan 2009). Therapeutic targets in pulmonary arterial hypertension. Pharmacol Ther. 121:69-88. DOI.
- Wilkins MR; Wharton J; Grimminger F; Ghofrani HA. (Jul 2008). Phosphodiesterase inhibitors for the treatment of pulmonary hypertension. Eur Respir J. 32:198-209. DOI.
- Diller G-P; van Eijl S; Okonko DO; Howard LS; Ali O; Thum T; Wort SJ; Bedard E; et alGibbs JSR; Bauersachs J; Hobbs AJ; Wilkins MR; Gatzoulis MA; Wharton J. (10 Jun 2008). Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. CIRCULATION. 117:3020-3030. Author weblink DOI.
- Diller GP; Okonko D; van Eijl S; Ali O; Howard LS; Wort SJ; Thum T; Gibbs SR; et alBauersachs J; Wilkins MR; Wharton J; Gatzoulis MA. (16 Oct 2007). Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. CIRCULATION. 116:661-662. Author weblink.
- Ali O; Wharton J; Gibbs JS; Howard L; Wilkins MR. (Jun 2007). Emerging therapies for pulmonary arterial hypertension. Expert Opin Investig Drugs. 16:803-818. DOI.
- Growcott EJ; Spink KG; Ren X; Afzal S; Banner KH; Wharton J. (2006). Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells. Respir Res. 7:9. DOI.
- Growcott EJ; Banner KH; Wharton J. (Dec 2005). Hypoxia amplifies the proliferative capacity of distal human pulmonary artery smooth-muscle cells. Chest. 128:600S-601S. DOI.
- Aldashev AA; Kojonazarov BK; Amatov TA; Sooronbaev TM; Mirrakhimov MM; Morrell NW; Wharton J; Wilkins MR. (Aug 2005). Phosphodiesterase type 5 and high altitude pulmonary hypertension. Thorax. 60:683-687. DOI.
- Wharton J; Strange JW; Møller GM; Growcott EJ; Ren X; Franklyn AP; Phillips SC; Wilkins MR. (1 Jul 2005). Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells. Am J Respir Crit Care Med. 172:105-113. DOI.
- Hafizi S; Wharton J; Chester AH; Yacoub MH. (2004). Profibrotic effects of endothelin-1 via the ETA receptor in cultured human cardiac fibroblasts. Cell Physiol Biochem. 14:285-292. DOI.
- Sebkhi A; Strange JW; Phillips SC; Wharton J; Wilkins MR. (1 Jul 2003). Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension. Circulation. 107:3230-3235. DOI.
- Gibbs JSR; Wharton J; Wilkins MR. (1 Feb 2003). Pulmonary arterial hypertension and the vasoconstrictive factor: is there still a role for vasodilator testing?. EUROPEAN HEART JOURNAL. 24:297-298. DOI.
- Yang X; Sheares KK; Davie N; Upton PD; Taylor GW; Horsley J; Wharton J; Morrell NW. (Dec 2002). Hypoxic induction of cox-2 regulates proliferation of human pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol. 27:688-696.
- Wilkins MR; Møller GM; Ren X; Wharton J. (Jun 2002). Developments in therapeutics for pulmonary arterial hypertension. Minerva Cardioangiol. 50:175-187.
- Strange JW; Wharton J; Phillips PG; Wilkins MR. (Mar 2002). Recent insights into the pathogenesis and therapeutics of pulmonary hypertension. Clin Sci (Lond). 102:253-268.
- Davie N; Haleen SJ; Upton PD; Polak JM; Yacoub MH; Morrell NW; Wharton J. (1 Feb 2002). ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med. 165:398-405.
- Wilkins MR; Wharton J. (Dec 2001). Progress in, and future prospects for, the treatment of primary pulmonary hypertension. Heart. 86:603-604.
- Upton PD; Wharton J; Davie N; Ghatei MA; Smith DM; Morrell NW. (Sep 2001). Differential adrenomedullin release and endothelin receptor expression in distinct subpopulations of human airway smooth-muscle cells. Am J Respir Cell Mol Biol. 25:316-325.
- Upton PD; Wharton J; Coppock H; Davie N; Yang X; Yacoub MH; Ghatei MA; Polak JM; et alBloom SR; Smith DM; Morrell NW. (Feb 2001). Adrenomedullin expression and growth inhibitory effects in distinct pulmonary artery smooth muscle cell subpopulations. Am J Respir Cell Mol Biol. 24:170-178.
- Wharton J; Davie N; Upton PD; Yacoub MH; Polak JM; Morrell NW. (19 Dec 2000). Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells. CIRCULATION. 102:3130-3136. Author weblink.
- Borland JAA; Chester AH; Rooker SJ; Wharton J; Davie N; Amrani M; Yacoub MH. (1 Dec 2000). Expression and function of angiotensin converting enzyme, chymase, and angiotensin II in the human radial artery and internal thoracic artery. ANNALS OF THORACIC SURGERY. 70:2054-2063. Author weblink DOI.
- Yang X; Davie N; Upton PD; Taylor GW; Wharton J; Morrell NW. (1 Dec 2000). Stimulation and inhibition of distal pulmonary artery smooth muscle cell growth by hypoxia. THORAX. 55:A35-A35. Author weblink.
- Walsh DA; Catravas J; Wharton J. (1 Feb 2000). Angiotensin converting enzyme in human synovium: increased stromal [I-125]351A binding in rheumatoid arthritis. ANNALS OF THE RHEUMATIC DISEASES. 59:125-131. Author weblink DOI.
- Morrell NW; Yang X; Upton PD; Yacoub MH; Polak JM; Wharton J. (1 Dec 1999). Pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension exhibit enhanced growth responses to IGF-1 and bFGF. THORAX. 54:A38-A38. Author weblink.
- Upton PD; Wharton J; Yang X; Ghatei MA; Bloom SR; Morrell NW. (1 Dec 1999). Two distinct smooth muscle subpopulations isolated from the human airway differ in endothelin receptor expression and adrenomedullin release. THORAX. 54:A8-A8. Author weblink.
- Morrell NW; Upton PD; Kotecha S; Huntley A; Yacoub MH; Polak JM; Wharton J. (Sep 1999). Angiotensin II activates MAPK and stimulates growth of human pulmonary artery smooth muscle via AT1 receptors. Am J Physiol. 277:L440-L448.
- Banning AP; Groves PH; Buttery LDK; Wharton J; Rutherford RAD; Black P; Winkler F; Polak JM; et alLewis MJ; Drexler H. (1 Jul 1999). Reciprocal changes in endothelial and inducible nitric oxide synthase expression following carotid angioplasty in the pig. ATHEROSCLEROSIS. 145:17-32. Author weblink DOI.
- Upton PD; Wharton J; Coppock HA; Smith DM; Ghatei MA; Bloom SR; Morrell NW. (1 Mar 1999). Adrenomedullin (AM), a vasodilator peptide secreted by human pulmonary artery-derived cells, increases intracellular cAMP and inhibits DNA synthesis. BRITISH JOURNAL OF PHARMACOLOGY. 126:U75-U75. Author weblink.
- Morrell NW; Yang X; Upton PD; Yacoub MH; Polak JM; Wharton J. (1 Mar 1999). Altered growth responses of human pulmonary artery smooth muscle and neointimal cells from patients with pulmonary hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 159:A696-A696. Author weblink.
- Wharton J; Chang SE; Upton PD; Guirez AR; Ghatei MA; Bloom SR; Polak JM; Tetley TD; et alMorrell NW. (1 Mar 1999). Autocrine role of endothelin in human small airway epithelial cells and modulation by cytokines. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 159:A178-A178.
- Morrell NW; Phillips PG; Yang X; Upton PD; Yacoub MH; Polack JM; Wharton J. (1 Mar 1999). Iloprost and isoproterenol inhibit PDGF-stimulated DNA synthesis in human pulmonary artery smooth muscle cells. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 159:A158-A158. Author weblink.
- Hafizi S; Wharton J; Morgan K; Allen SP; Chester AH; Catravas JD; Polak JM; Yacoub MH. (8 Dec 1998). Expression of functional angiotensin-converting enzyme and AT(1) receptors in cultured human cardiac fibroblasts. CIRCULATION. 98:2553-2559. Author weblink.
- Upton PD; Wharton J; Coppock H; Smith DM; Ghatel MA; Bloom SR; Morrell NW. (27 Oct 1998). Adrenomedullin inhibits PDGF-stimulated DNA synthesis and ET-1 release in human pulmonary artery smooth muscle cells. CIRCULATION. 98:341-341. Author weblink.
- Hafizi S; Wharton J; Chester AH; Polak JM; Yacoub MH. (27 Oct 1998). Endothelin-1 stimulates collagen synthesis in cultured human cardiac fibroblasts via the ETA receptor. CIRCULATION. 98:179-179. Author weblink.
- Wharton J; Morgan K; Rutherford RA; Catravas JD; Chester A; Whitehead BF; De Leval MR; Yacoub MH; et alPolak JM. (Jan 1998). Differential distribution of angiotensin AT2 receptors in the normal and failing human heart. J Pharmacol Exp Ther. 284:323-336.
- Brown LA; Rutherford RAD; Nunez DJR; Wharton J; Lowe DG; Wilkins MR. (1 Dec 1997). Downregulation of natriuretic peptide C-receptor protein in the hypertrophied ventricle of the aortovenocaval fistula rat. CARDIOVASCULAR RESEARCH. 36:363-371. Author weblink DOI.
- Morrell NW; Upton PD; Higham MA; Yacoub MH; Polak JM; Wharton J. (21 Oct 1997). Localization of angiotensin II receptor subtypes in human pulmonary artery and AT(1) mediated smooth muscle cell growth responses in vitro. CIRCULATION. 96:332-332. Author weblink.
- Walsh DA; Hu DE; Wharton J; Catravas JD; Blake DR; Fan TPD. (1 Apr 1997). Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma. BRITISH JOURNAL OF PHARMACOLOGY. 120:1302-1311. DOI.
- Crick SJ; Sheppard MN; Anderson RH; Polak JM; Wharton J. (Aug 1996). A quantitative assessment of innervation in the conduction system of the calf heart. Anat Rec. 245:685-698. DOI.
- Marron K; Yacoub MH; Polak JM; Sheppard MN; Fagan D; Whitehead BF; de Leval MR; Anderson RH; et alWharton J. (1 Aug 1996). Innervation of human atrioventricular and arterial valves. Circulation. 94:368-375.
- Crick SJ; Sheppard MN; Anderson RH; Polak JM; Wharton J. (Apr 1996). A quantitative study of nerve distribution in the conduction system of the guinea pig heart. J Anat. 188 ( Pt 2):403-416.
- Rutherford RA; McCarthy A; Sullivan MH; Elder MG; Polak JM; Wharton J. (Dec 1995). Nitric oxide synthase in human placenta and umbilical cord from normal, intrauterine growth-retarded and pre-eclamptic pregnancies. Br J Pharmacol. 116:3099-3109.
- YOU JP; GULBENKIAN S; OLESEN IJ; MARRON K; WHARTON J; BARROSO CP; POLAK JM; EDVINSSON L. (6 Nov 1995). PEPTIDERGIC INNERVATION OF GUINEA-PIG BRAIN VESSELS - COMPARISON WITH IMMUNOHISTOCHEMISTRY AND IN-VITRO PHARMACOLOGY IN ROSTRALLY AND CAUDALLY LOCATED ARTERIES. JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM. 55:179-188. Author weblink DOI.
- Walsh DA; Salmon M; Featherstone R; Wharton J; Church MK; Polak JM. (Dec 1994). Differences in the distribution and characteristics of tachykinin NK1 binding sites between human and guinea pig lung. Br J Pharmacol. 113:1407-1415.
- Knock GA; Sullivan MH; McCarthy A; Elder MG; Polak JM; Wharton J. (Nov 1994). Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies. J Pharmacol Exp Ther. 271:1007-1015.
- RUTHERFORD RAD; MATSUDA Y; WILKINS MR; POLAK JM; WHARTON J. (1 Nov 1994). IDENTIFICATION OF RENAL NATRIURETIC PEPTIDE RECEPTOR SUBPOPULATIONS BY USE OF THE NONPEPTIDE ANTAGONIST, HS-142-1. BRITISH JOURNAL OF PHARMACOLOGY. 113:931-939. Author weblink.
- Morgan K; Wharton J; Webb JC; Keogh BE; Smith PL; Taylor KM; Oakley CM; Polak JM; et alCleland JG. (Jul 1994). Co-expression of renin-angiotensin system component genes in human atrial tissue. J Hypertens Suppl. 12:S11-S19.
- Walsh DA; Suzuki T; Knock GA; Blake DR; Polak JM; Wharton J. (Jun 1994). AT1 receptor characteristics of angiotensin analogue binding in human synovium. Br J Pharmacol. 112:435-442.
- Gaer JA; Gordon L; Wharton J; Polak JM; Taylor KM; McKenna W; Parker DJ. (Dec 1993). Intractable chest pain in cardiomyopathy: treatment by a novel technique of cardiac cryodenervation with quantitative immunohistochemical assessment of success. Br Heart J. 70:574-577.
- Gordon L; Polak JM; Moscoso GJ; Smith A; Kuhn DM; Wharton J. (Aug 1993). Development of the peptidergic innervation of human heart. J Anat. 183 ( Pt 1):131-140.
- Rutherford RA; Wharton J; McCarthy A; Gordon L; Sullivan MH; Elder MG; Polak JM. (Jun 1993). Differential localization of endothelin ETA and ETB binding sites in human placenta. Br J Pharmacol. 109:544-552.
- Wharton J; Gordon L; Byrne J; Herzog H; Selbie LA; Moore K; Sullivan MH; Elder MG; et alMoscoso G; Taylor KM. (15 Jan 1993). Expression of the human neuropeptide tyrosine Y1 receptor. Proc Natl Acad Sci U S A. 90:687-691.
- Knock GA; Wharton J; Gaer JA; Yacoub MH; Taylor KM; Polak JM. (4 Sep 1992). Regional distribution and regulation of [125I]calcitonin gene-related peptide binding sites in coronary arteries. Eur J Pharmacol. 219:415-425.
- WALSH DA; MAPP PI; WHARTON J; RUTHERFORD RAD; KIDD BL; REVELL PA; BLAKE DR; POLAK JM. (1 Mar 1992). LOCALIZATION AND CHARACTERIZATION OF SUBSTANCE-P BINDING TO HUMAN SYNOVIAL TISSUE IN RHEUMATOID-ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. 51:313-317. Author weblink DOI.
- Gaer JA; Wharton J; Gordon L; Swift RI; Munsch C; Inglis GC; Polak JM; Taylor KM. (1992). Cardiac denervation in the calf using cryoablation: functional evidence and regional tissue catecholamine content. Eur J Cardiothorac Surg. 6:201-208.
- POWER RF; WHARTON J; ZHAO Y; BLOOM S; POLAK JM. (1 Jan 1989). AUTORADIOGRAPHIC LOCALIZATION OF ENDOTHELIN-1 BINDING-SITES IN THE CARDIOVASCULAR AND RESPIRATORY SYSTEMS. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 13:S50-S56. Author weblink DOI.
- WHARTON J; ANDERSON RH; ESPEJO R; SMITH A; PENKETH R; POLAK JM. (1 Jan 1989). DEVELOPMENT OF PEPTIDE CONTAINING NEURAL AND ENDOCRINE ELEMENTS IN THE HUMAN-HEART. BRITISH HEART JOURNAL. 61:112-112. Author weblink.
- Wharton J; Gulbenkian S; Merighi A; Kuhn DM; Jahn R; Taylor KM; Polak JM. (Oct 1988). Immunohistochemical and ultrastructural localisation of peptide-containing nerves and myocardial cells in the human atrial appendage. Cell Tissue Res. 254:155-166.
- MCMILLAN I; STEWART J; LINDOP G; BRADLEY JA; WHARTON J; POLAK J; BROWN WB. (1 Jun 1988). RENAL NERVES IN MINERALOCORTICOID-INDUCED HYPERTENSION. BRITISH JOURNAL OF SURGERY. 75:613-613. Author weblink.
- Meleagros L; Ghatei MA; Anderson JV; Wharton J; Taylor KM; Krikler DM; Meijler FL; Polak JM; et alBloom SR. (15 Mar 1988). The presence and molecular forms of cardiodilatin immunoreactivity in the human and rat right atrium. Clin Chim Acta. 172:199-209.
- Springall DR; Bhatnagar M; Wharton J; Hamid Q; Gulbenkian S; Hedges M; Meleagros L; Bloom SR; et alPolak JM. (Jan 1988). Expression of the atrial natriuretic peptide gene in the cardiac muscle of rat extrapulmonary and intrapulmonary veins. Thorax. 43:44-52.
- ALM P; LUNDBERG LM; WHARTON J; POLAK JM. (1 Jan 1988). ONTOGENETIC DEVELOPMENT OF THE GUINEA-PIG UTERINE INNERVATION - AN IMMUNOHISTOCHEMICAL STUDY OF DIFFERENT NEURONAL MARKERS, NEUROPEPTIDES AND S-100 PROTEIN. HISTOCHEMISTRY. 90:19-24. Author weblink DOI.
- WHARTON J; HAWORTH SG; POLAK JM. (1 Jan 1988). POSTNATAL-DEVELOPMENT OF THE INNERVATION AND PARAGANGLIA IN THE PORCINE PULMONARY ARTERIAL BED. JOURNAL OF PATHOLOGY. 154:19-27. Author weblink DOI.
- GHATINEH S; ANDERSON JV; WHARTON J; WYSE R; ELLIOTT MJ; POLAK JM; BLOOM S. (1 Sep 1986). ATRIAL-NATRIURETIC-PEPTIDE (ANP) IS STORED ONLY AS THE PROHORMONE IN HUMAN-HEART. REGULATORY PEPTIDES. 15:177-177. Author weblink DOI.
- TERENGHI G; MCGREGOR GP; BHUTTACHARJI S; WHARTON J; BLOOM S; POLAK JM. (1 Jan 1983). VAGAL ORIGIN OF SUBSTANCE P-CONTAINING NERVES IN THE GUINEA-PIG LUNG. NEUROSCIENCE LETTERS. 36:229-236. Author weblink DOI.
- COLE GA; POLAK JM; WHARTON J; MARANGOS P; PEARSE AGE. (1 Jan 1980). NEURON SPECIFIC ENOLASE AS A USEFUL HISTOCHEMICAL MARKER FOR THE NEURO-ENDOCRINE SYSTEM OF THE LUNG. JOURNAL OF PATHOLOGY. 132:351-352. Author weblink.
- POLAK JM; WHARTON J; BISHOP AE; MCGREGOR GP; BLOOM S. (1 Jan 1980). SUBSTANCE P-LIKE IMMUNOREACTIVE NERVES IN THE HEART. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY. 28:618-618. Author weblink.
- WHARTON J; POLAK JM; BLOOM S; WILL JA; BROWN MR; PEARSE AGE. (1 Jan 1979). SUBSTANCE P-LIKE IMMUNOREACTIVE NERVES IN MAMMALIAN LUNG. INVESTIGATIVE & CELL PATHOLOGY. 2:3-10. Author weblink.
- WHARTON J; POLAK JM; BLOOM S; GHATEI MA; SOLCIA E; BROWN MR; PEARSE AGE. (1 Jan 1978). BOMBESIN-LIKE IMMUNOREACTIVITY IN LUNG. NATURE. 273:769-770. Author weblink DOI.
Books
- Wharton J; Polak JM. Wharton J (ed); Polak JM (ed). Receptor Autoradiography - Principles and Practice. Oxford University Press, Oxford (1993).
Conferences
- Diller G-P; Okonko DO; Wort JS; Wilkins MR; Wharton J; Gatzoulis MA. Endothelial progenitor cells in patients with eisenmenger syndrome or idiopathic pulmonary arterial hypertension. 56th Annual Scientific Session of the American-College-of-Cardiology, 24 Mar 2007 - 27 Mar 2007. 49:269A-269A. ELSEVIER SCIENCE INC (6 Mar 2007). Author weblink.
- Ali O; Growcott EJ; Wilkins MR; Wharton J. Anti-proliferative and pro-apoptotic effects of statins in human pulmonary artery smooth muscle cells. 79th Annual Scientific Session of the American-Heart-Association, 12 Nov 2006 - 15 Nov 2006. 114:81-81. LIPPINCOTT WILLIAMS & WILKINS (31 Oct 2006). Author weblink.
- Ali O; Growcott E; Wharton J; Wilkins M. Statins modulate the growth of human pulmonary smooth muscle cells through the mevalonate pathway. Annual Scientific Conference of the British-Society-Promoting-Cardiovascular-Health. 92:A14-A15. (May 2006).
- Sebkhi A; Strange J; Phillips SC; Wharton J; Wilkins MR. Distribution of phosphodiesterase type 5 (PDE5) and effect of its inhibition in chronic hypoxic rat lung. 19th Meeting of the International-Society-for-Hypertension/12th European-Society-of-Hypertension Meeting. 20:S281-S281. (Jun 2002).
- TERENGHI G; BULL HA; BUNKER CB; SPRINGALL DR; ZHAO Y; WHARTON J; DOWD PM; POLAK JM. ENDOTHELIN-1 IN HUMAN SKIN - IMMUNOHISTOCHEMICAL, RECEPTOR-BINDING, AND FUNCTIONAL-STUDIES. 2ND INTERNATIONAL CONF ON ENDOTHELIN, 9 Dec 1990 - 12 Dec 1990. 17:S467-S470. LIPPINCOTT-RAVEN PUBL (1 Jan 1991). Author weblink DOI.


